Hadassah

Hadassah Announces 97 Percent Success Rate with New Hepatitis C Treatment

Monday, Aug 24 2015

The treatment is a combination of Viekarax and Exviera, and was developed by AbbVie, it has now been approved by the Federal Drug Administration and Israel’s Ministry of Health.

“Hepatitis C used to be a death sentence,” reports Prof. Rifaat Safadi, head of the Liver Unit at the Hadassah Medical Organization. He explains, however, that Hadassah has achieved 97 percent success in treating the disease using a new combination of medicines clinically tested at Hadassah and other leading medical centers worldwide.

One of the 100 patients to receive the treatment at Hadassah was Ava Avidar, a mother of three who had undergone a liver transplant. Tragically, she had previously contracted Hepatitis C and the virus which remained in her body attacked her new liver, too. The medicine defeated the virus, however, and she is now doing very well, according to Prof. Safadi. As Mrs. Avidar relates, “It’s nothing short of getting my life back as a gift.”

Now six months post treatment, Mrs. Avidar is free of the virus, has moved to a new home, and returned to her work as a sculptress.

Recalling the journey to health for Mrs. Avidar, Prof. Safadi says: “We began a race against the clock and had to come up with an urgent solution before the new liver failed.” While the new treatment had not yet been approved by Israel’s Ministry of Health, Prof. Safadi believed the medication would save her. Still, his patient could not afford the $100,000 it would cost for the three months of treatment. Fortunately, Mrs. Avidar found the strength to fight her private health insurance company and won her battle, Prof. Safadi relates. 

The treatment, a combination of Viekarax and Exviera, developed by AbbVie, has now been approved by the Federal Drug Administration and Israel’s Ministry of Health, thanks to the success achieved at Hadassah and the other international clinical trials. Prof. Sifadi was also instrumental in getting the new treatment incorporated into Israel’s 2015 health insurance basket, so patients can now receive coverage for this life-saving treatment.

Comments

From: nancy Russo on March 7, 2016
If Gilead is an Isralie drug company how come you didn't use Harvoni?
From: Mary on September 5, 2015
With the medicines for Hep C, do you have anything working for pancreatic cancer?
From: Janet on August 27, 2015
Can you help????
From: Sharon on August 26, 2015
This is Wonderful news! I was a Hep C advocate and patient on the old regimen in 1999 and started a non profit HCV support group. The old meds were very hard on the body with many side effects & after 1 year on this I have been viral free for 15 yrs! Thank You Hadassah Hospital for your continued research to improve the cure rate for this horrific liver disease that millions have and may not even know. Keep up All your Wonderful Work!
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 22 2017

Hadassah Medical Organization Performs Israel’s First Spina Bifida Fetal Surgery To Lessen Crippling Spinal Damage

History was made at Hadassah Ein Kerem Hospital in Jerusalem on Thursday, February 9 when a team of Israeli surgeons successfully operated on a 5-month-old fetus using a new procedure that only three doctors in the world can perform, to alleviate some of the crippling effects of Spina Bifida.

READ MORE ›
alt_text

Tuesday, Feb 21 2017

Hadassah Cardiologists Publicize Israel’s Dramatic Decrease in Cardiovascular Death

Prof. Emeritus Mervyn Gotsman and Prof. Israel Gotsman of Hadassah Hospital’s Heart Institute have coauthored an article which appeared in the European Heart Journal, highlighting the fact that “between 1998 and 2012, mortality from cardiovascular disease in Israel has fallen from 162 to 80 per 100,000 residents--a decrease of 50 percent.”

READ MORE ›
alt_text

Tuesday, Feb 21 2017

Ambassadors of Health for Heart Smart Living: A Unique Hadassah Program

Knowing that the workplace is where people spend vast quantities of time, the Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women launched a unique course to encourage heart healthy living—during the work day.

READ MORE ›
alt_text

Tuesday, Feb 21 2017

Hadassah Brings Health Empowerment to East Jerusalem

The increased incidence of diabetes in the Arab community, as well as the 60 percent higher rate of cardiovascular mortality among Arab women led the Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women to develop a community-based program to cultivate leadership that embraces and advocates for healthy living which will reduce diabetes in this population.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More